Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia

Key Points Telomerase gene therapy in a mouse model of aplastic anemia targets the bone marrow and provides increased and stable telomerase expression. Telomerase expression leads to telomere elongation and subsequently to the reversal of aplastic anemia phenotypes.